FDA to require new warning of secondary cancer risk for CAR-T cancer therapies
[ The Food and Drug Administration (FDA) is requiring a boxed warning on all existing CAR-T cancer treatments following a review of reports that the therapies themselves can increase the risk for some secondary cancers. In letters to the manufacturers of all six currently available CAR-T therapies dated Jan. 19, the FDA said the prescribing … Read more
